Next Article in Journal
Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
Next Article in Special Issue
Unveiling the Therapeutic Horizon: HPV Vaccines and Their Impact on Cutaneous Diseases—A Comprehensive Review
Previous Article in Journal
COVID-19 Vaccinations, Trust, and Vaccination Decisions within the Refugee Community of Calgary, Canada
Previous Article in Special Issue
Cutaneous Manifestations of SARS-CoV-2, Cutaneous Adverse Reactions to Vaccines Anti-SARS-CoV-2 and Clinical/Dermoscopical Findings: Where We Are and Where We Will Go
 
 
Review

Article Versions Notes

Vaccines 2024, 12(2), 178; https://doi.org/10.3390/vaccines12020178
Action Date Notes Link
article xml file uploaded 9 February 2024 07:51 CET Original file -
article xml uploaded. 9 February 2024 07:51 CET Update https://www.mdpi.com/2076-393X/12/2/178/xml
article pdf uploaded. 9 February 2024 07:51 CET Version of Record https://www.mdpi.com/2076-393X/12/2/178/pdf
article html file updated 9 February 2024 07:53 CET Original file https://www.mdpi.com/2076-393X/12/2/178/html
Back to TopTop